Total Payments
$1,349
2024 Payments
$358.74
Companies
13
Transactions
77
Medicare Patients
1,188
Medicare Billing
$99,612
Payment Breakdown by Category
Food & Beverage$1,349 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,349 | 77 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $314.88 | 18 | $0 (2024) |
| Lilly USA, LLC | $312.83 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $246.80 | 15 | $0 (2024) |
| Novo Nordisk Inc | $231.35 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $57.50 | 3 | $0 (2024) |
| Exact Sciences Corporation | $47.25 | 3 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $37.39 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.94 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $17.15 | 1 | $0 (2024) |
| Abbott Laboratories | $16.85 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $358.74 | 19 | AstraZeneca Pharmaceuticals LP ($98.75) |
| 2023 | $635.80 | 36 | Lilly USA, LLC ($211.90) |
| 2022 | $280.11 | 18 | ABBVIE INC. ($132.85) |
| 2021 | $74.41 | 4 | Novo Nordisk Inc ($52.98) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: VACCINES | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Respiratory | ||||||
| 07/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Diabetes | ||||||
| 05/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Diabetes | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/25/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: PAIN | ||||||
| 03/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Oncology | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Respiratory | ||||||
| 02/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Respiratory | ||||||
| 02/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Diabetes | ||||||
| 01/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Diabetes | ||||||
| 12/20/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Respiratory | ||||||
| 12/05/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 280 | 309 | $80,468 | $25,201 |
| 2022 | 5 | 310 | 351 | $91,225 | $27,711 |
| 2021 | 6 | 308 | 370 | $88,297 | $26,368 |
| 2020 | 3 | 290 | 372 | $88,618 | $20,333 |
Total Patients
1,188
Total Services
1,402
Medicare Billing
$99,612
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 121 | 121 | $35,816 | $13,138 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 85 | $23,205 | $6,187 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 90 | $16,650 | $4,536 | 27.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 13 | $4,797 | $1,340 | 27.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 106 | 106 | $31,376 | $11,711 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 116 | $31,668 | $8,716 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 85 | $15,725 | $3,742 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 32 | $11,808 | $3,359 | 28.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 12 | 12 | $648.00 | $183.40 | 28.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 73 | 73 | $21,608 | $8,340 | 38.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 117 | 156 | $28,860 | $8,189 | 28.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 98 | $26,754 | $7,200 | 26.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 20 | $7,380 | $1,922 | 26.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $3,047 | $549.01 | 18.0% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 12 | 12 | $648.00 | $168.63 | 26.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 124 | 172 | $46,956 | $9,776 | 20.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 124 | 158 | $29,230 | $6,360 | 21.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 42 | 42 | $12,432 | $4,196 | 33.8% |
About Alan Meredith, PAC
Alan Meredith, PAC is a Physician Assistant healthcare provider based in Waterloo, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2012. The National Provider Identifier (NPI) number assigned to this provider is 1053656298.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alan Meredith, PAC has received a total of $1,349 in payments from pharmaceutical and medical device companies, with $358.74 received in 2024. These payments were reported across 77 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,349).
As a Medicare-enrolled provider, Meredith has provided services to 1,188 Medicare beneficiaries, totaling 1,402 services with total Medicare billing of $99,612. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Waterloo, IL
- Active Since 11/28/2012
- Last Updated 04/30/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1053656298
Products in Payments
- MOUNJARO (Drug) $222.23
- QULIPTA (Drug) $154.48
- Ozempic (Drug) $131.67
- UBRELVY (Drug) $130.95
- BREZTRI (Drug) $109.63
- FARXIGA (Drug) $101.11
- Rybelsus (Drug) $99.68
- ENTRESTO (Drug) $57.50
- Cologuard Collection Kit (Device) $47.25
- SEGLENTIS (Drug) $37.39
- TRULICITY (Drug) $36.11
- AIRSUPRA (Drug) $36.06
- EMGALITY (Drug) $34.53
- VRAYLAR (Drug) $29.45
- JARDIANCE (Drug) $19.96
- SHINGRIX (Biological) $17.15
- FREESTYLE LIBRE 2 (Device) $16.85
- NURTEC ODT (Drug) $16.29
- CONTRAVE (Drug) $15.82
- XIFAXAN (Drug) $14.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Waterloo
Mrs. Jessica Wachtel, Pa, PA
Physician Assistant — Payments: $3,062
Physician Assistant $3,062
Lyndsie Lujan, Pa-C, PA-C
Physician Assistant — Payments: $2,527
Physician Assistant $2,527
Hannah Schmit, Pa-C, PA-C
Physician Assistant — Payments: $1,894
Physician Assistant $1,894
Christine Mitchell, Pa-C, PA-C
Physician Assistant — Payments: $1,357
Physician Assistant $1,357
Kenneth Mathis, R.p.a, R.P.A
Physician Assistant — Payments: $1,077
Physician Assistant $1,077
Eric Dolash, Pa-C, PA-C
Physician Assistant — Payments: $643.11
Physician Assistant $643.11